Table 3.
Rates of Thromboembolic Complications and ICH recurrence
| Study | Anticoagulant Medications | No Anticoagulant Medications | ||||
|---|---|---|---|---|---|---|
| Stroke+MI (%) | ICH recurrence (%) | Total Population | Stroke+MI (%) | ICH recurrence (%) | Total Population | |
| De Vleeschouwer et al17 | 0 (0) | 1 (4.0) | 25 | 3 (3.7) | 7 (8.6) | 81 |
| Classen et al18 | 6 (26.1) | 1 (4.3) | 23 | 8 (32.0) | 0 (0) | 25 |
| Majeed et al20 | 1 (2.2) | 8 (17.8) | 45 | 18 (20.7) | 10 (11.5) | 87 |
| Yung et al19 | N/A | 14 (15.4) | 91 | N/A | 29 (15.0) | 193 |
| Gathier et al12 | 2 (16.7) | 1 (8.3) | 12 | 2 (15.4) | 0 (0) | 13 |
| Nielsen et al16 | 35 (6.9) | 36 (7.1) | 509 | 108 (21.4) | 72 (14.3) | 505 |
| Kuramatsu et al11 | 9 (5.2) | 14 (8.1) | 172 | 82 (14.9) | 36 (6.6) | 547 |
| Ottosen et al15 | N/A | 91 (8.9) | 1022 | N/A | 113 (5.8) | 1,956 |
| Total Events | 53 (6.7)a | 166 (8.7) | 1,899 | 221 (17.6)a | 267 (7.8) | 3,407 |
Abbreviations: ICH, intracranial hemorrhage; MI, myocardial infarction; N/A, not available
a
Studies by Yung et al. and Ottosen et al. were excluded since stroke and MI were not reported